A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
An inspection and review conducted by South Korea’s authorities found that most of the supplements of questionable quality being sold only were from US brands.
The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.
An upcoming symposium will explore the toxicology, pharmacokinetics, analysis, and regulatory perspectives of pyrrolizidine alkaloids, toxic compounds that may be found in food and herbal products.
Interest in personalized nutrition is surging, increasing more than threefold between 2017 and 2019. With more than a billion people worldwide diagnosed with diet-related diseases, costs for their care has jumped to more than $1 trillion dollars a year....
Nascent hemp/CBD firms are often woefully unprepared for the regulatory compliance side of operating a dietary supplement firm, something an upcoming industry event aims to help fix.
New York-based Gemini Pharmaceuticals has achieved International Standard ISO/IEC 17025:2017 accreditation for Testing Laboratory from ANSI National Accreditation Board (ANAB) for its in-house analytical laboratory.
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
